Evidence map›Paper›PMID 25633992›Full record

ArticlePloS one2015

Diet is critical for prolonged glycemic control after short-term insulin treatment in high-fat diet-induced type 2 diabetic male mice.

Aili Guo, Nigel A Daniels, Jean Thuma, Kelly D McCall, Ramiro Malgor, Frank L Schwartz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aili GuoOhio University Heritage College of Osteopathic Medicine, Athens, Ohio 45701, United States of America; The Diabetes Institute at Ohio University, Athens, Ohio 45701, United States of America.
Nigel A DanielsOhio University Heritage College of Osteopathic Medicine, Athens, Ohio 45701, United States of America; The Diabetes Institute at Ohio University, Athens, Ohio 45701, United States of America.
Jean ThumaOhio University Heritage College of Osteopathic Medicine, Athens, Ohio 45701, United States of America; The Diabetes Institute at Ohio University, Athens, Ohio 45701, United States of America.
Kelly D McCallOhio University Heritage College of Osteopathic Medicine, Athens, Ohio 45701, United States of America; The Diabetes Institute at Ohio University, Athens, Ohio 45701, United States of America.
Ramiro MalgorOhio University Heritage College of Osteopathic Medicine, Athens, Ohio 45701, United States of America; The Diabetes Institute at Ohio University, Athens, Ohio 45701, United States of America.
Frank L SchwartzOhio University Heritage College of Osteopathic Medicine, Athens, Ohio 45701, United States of America; The Diabetes Institute at Ohio University, Athens, Ohio 45701, United States of America.
Ohio University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (T2DM) can promote prolonged glycemic control. The purpose of this study was to establish an animal model to examine such a "legacy" effect of early insulin therapy (EIT) in long-term glycemic control in new-onset T2DM. The objective of the study was to investigate the role of diet following onset of diabetes in the favorable outcomes of EIT. METHODOLOGY: As such, C57BL6/J male mice were fed a high-fat diet (HFD) for 21 weeks to induce diabetes and then received 4 weeks of daily insulin glargine or sham subcutaneous injections. Subsequently, mice were either kept on the HFD or switched to a low-fat diet (LFD) for 4 additional weeks. PRINCIPAL

findingsMice fed a HFD gained significant fat mass and displayed increased leptin levels, increasing insulin resistance (poor HOMA-IR) and worse glucose tolerance test (GTT) performance in comparison to mice fed a LFD, as expected. Insulin-treated diabetic mice but maintained on the HFD demonstrated even greater weight gain and insulin resistance compared to sham-treated mice. However, insulin-treated mice switched to the LFD exhibited a better HOMA-IR compared to those mice left on a HFD. Further, between the insulin-treated and sham control mice, in spite of similar HOMA-IR values, the insulin-treated mice switched to a LFD following insulin therapy did demonstrate significantly better HOMA-B% values than sham control and insulin-treated HFD mice. CONCLUSION/

interpretationEarly insulin treatment in HFD-induced T2DM in C57BL6/J mice was only beneficial in animals that were switched to a LFD after insulin treatment which may explain why a similar legacy effect in humans is achieved clinically in only a portion of cases studied, emphasizing a vital role for diet adherence in diabetes control.

Indexed as

DietDiet, High-FatAnimalsBlood GlucoseDiabetes Mellitus, Type 2Hypoglycemic AgentsInsulinInsulin ResistanceLeptinMaleMiceBlood GlucoseHypoglycemic AgentsInsulinLeptin

Identifiers

PMID25633992
PMCPMC4310595
OpenAlexW2006450971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.